Community Acquired Pneumonia: Controversies and Questions, an Issue of Infectious Disease Clinics, 1st Edition
Author :
By Thomas M. File Jr., MD
Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefi
...view more
Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefits of identifying biomarkers for management of CAP (which could someday become a part of routine diagnostic testing for CAP), the best therapies for influenza/viral causes of pneumonia (the most common form of the disease in children), and clinical scoring tools to help predict long term outcomes. The issue also discusses how to approach MRSA as a cause of CAP and how to approach the non-responding patient.
Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefits of identifying biomarkers for management of CAP (which could someday become a part of routine diagnostic testing for CAP), the best therapies for influenza/viral causes of pneumonia (the most common form of the disease in children), and clinical scoring tools to help predict long term outcomes. The issue also discusses how to approach MRSA as a cause of CAP and how to approach the non-responding patient.
Author Information
By Thomas M. File Jr., MD, Chief, Infectious Disease, Northeastern Ohio University College of Medicine
https://www.asia.elsevierhealth.com/community-acquired-pneumonia-controversies-and-questions-an-issue-of-infectious-disease-clinics-9781455771066.html300307Community Acquired Pneumonia: Controversies and Questions, an Issue of Infectious Disease Clinicshttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9781455771066_7.jpg89.0998.99USDInStock/Medicine & Surgery/Infectious Disease/Clinics/Medicine/Infectious Disease/Clinics/Clinics/Medicine/Infectious Disease/Japan Titles43351464388725505462350546665255041525986052631601418269243350884886536505455351451205259833Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefits of identifying biomarkers for management of CAP (which could someday become a part of routine diagnostic testing for CAP), the best therapies for influenza/viral causes of pneumonia (the most common form of the disease in children), and clinical scoring tools to help predict long term outcomes. The issue also discusses how to approach MRSA as a cause of CAP and how to approach the non-responding patient. Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefits of identifying biomarkers for management of CAP (which could someday become a part of routine diagnostic testing for CAP), the best therapies for influenza/viral causes of pneumonia (the most common form of the disease in children), and clinical scoring tools to help predict long term outcomes. The issue also discusses how to approach MRSA as a cause of CAP and how to approach the non-responding patient.00add-to-cart97814557710662013ProfessionalBy Thomas M. File Jr., MD20131BookOtherElsevier0Apr 3, 2013IN STOCKBy <STRONG>Thomas M. File Jr.</STRONG>, MD, Chief, Infectious Disease, Northeastern Ohio University College of MedicineClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
